Plasma Endothelial Glycocalyx Components as a Potential Biomarker for Predicting the Development of Disseminated Intravascular Coagulation in Patients With Sepsis

Abstract

Background:

Sepsis coagulopathy or disseminated intravascular coagulation (DIC) mainly due to progressive endothelial disruption and damage. The glycocalyx is expressed on the endothelial cell surface and contributes to anti-thrombogenicity, anti-inflammatory, and regulates vascular permeability. We aimed to evaluate the clinical utility of plasma glycocalyx components as biomarkers in predicting the onset of DIC in sepsis.

Materials and methods:

This was a prospective observational study of 45 patients with sepsis (June to December 2018). Demographic, clinical (Acute Physiology, Age, Chronic Health Evaluation II [APACHE II], Sequential Organ Failure Assessment [SOFA]), and laboratory data from medical records were analyzed. Endothelial glycocalyx components (syndecan-1, heparan sulfate, hyaluronan) were measured using an ELISA kit.

Results:

Among the 45 patients (23, sepsis; 22, septic shock), plasma syndecan-1, heparan sulfate, and hyaluronan levels were higher in those with septic shock and were positively correlated with disease severity as determined by the APACHE II and SOFA scores and lactate levels. Receiver operating characteristic curve analysis revealed high sensitivity and specificity of syndecan-1 for predicting septic shock. Further, these levels were compared between patients with or without the development of DIC. Plasma syndecan-1 and hyaluronan levels were significantly elevated in patients with DIC compared to those in patients without DIC and were strongly associated with activated partial thromboplastin time, prothrombin time, and platelet counts. Area under the curve values for predicting DIC based on syndecan-1 and hyaluronan levels measurements were 0.774 and 0.740, respectively.

Conclusions:

Increased plasma syndecan-1 and hyaluronan levels may be indicators of disease severity and useful predictors for DIC development in sepsis.

Keywords

sepsis/septic shock glycocalyx syndecan-1 hyaluronan disseminated intravascular coagulation

Get full access to this article

View all access options for this article.

References

Rhodes

Evans

Alhazzani

, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016. Intensive Care Med. 2017;43(3):304–377.

Singer

Deutschman

Seymour

, et al. The third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA. 2016;315(8):801–810.

Iba

Levi

Levy

. Sepsis-induced coagulopathy and disseminated intravascular coagulation. Semin Thromb Hemost. 2020;46(1):89–95.

Iba

Arakawa

Di Nisio

, et al. Newly proposed sepsis-induced coagulopathy precedes International Society on Thrombosis and Haemostasis overt-disseminated intravascular coagulation and predicts high mortality. J Intensive Care Med. 2020;35(7):643–649.

Iba

Ito

Maruyama

, et al. Potential diagnostic markers for disseminated intravascular coagulation of sepsis. Blood Rev. 2016;30(2):149–155.

Marcel

Tom

. Coagulation and sepsis. Thromb Res. 2017;149:38–44.

Cross

Drury

Hill

Pollard

. Epigenetics in sepsis: understanding its role in endothelial dysfunction, immunosuppression, and potential therapeutics. Front Immunol. 2019;18(10):1363.

Van Teeffelen

Brands

Stroes

Vink

. Endothelial glycocalyx: sweet shield of blood vessels. Trends Cardiovasc Med. 2007;17:101–105.

LaRivière

Schmidt

. The pulmonary endothelial glycocalyx in ARDS: a critical role for heparan sulfate. Curr Top Membr. 2018;82:33–52.

10.

Pillinger

Kam

. Endothelial glycocalyx: basic science and clinical implications. Anaesth Intensive Care. 2017;45(3):295–307.

11.

Korakas

Ikonomidis

Markakis

Raptis

Dimitriadis

Lambadiari

. The endothelial glycocalyx as a key mediator of albumin handling and the development of diabetic nephropathy. Curr Vasc Pharmacol. 2019. DOI:10.2174/1570161118666191224120242

12.

Wei

Gonzalez Rodriguez

Chang

, et al. Elevated syndecan-1 after trauma and risk of sepsis: a secondary analysis of patients from the pragmatic, randomized optimal platelet and plasma ratios (PROPPR) trial. J Am Coll Surg. 2018;227(6):587–595.

13.

Uchimido

Schmidt

Shapiro

. The glycocalyx: a novel diagnostic and therapeutic target in sepsis. Crit Care. 2019;23(1):16.

14.

Chappell

Brettner

Doerfler

, et al. Protection of glycocalyx decreases platelet adhesion after ischaemia/reperfusion: an animal study. Eur J Anaesthesiol. 2014;31(9):474–481.

15.

Halbgebauer

Braun

Denk

, et al. Hemorrhagic shock drives glycocalyx, barrier and organ dysfunction early after polytrauma. J Crit Care. 2018;44:229–237.

16.

Taylor

Jr Toh

Hoots

Wada

Levi

. Scientific Subcommittee on Disseminated Intravascular Coagulation (DIC) of the International Society on Thrombosis and Haemostasis (ISTH). Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Thromb Haemost. 2001;86(5):1327–1330.

17.

Luo

Niu

. A multicenter, prospective evaluation of the Chinese Society of Thrombosis and Hemostasis Scoring System for disseminated intravascular coagulation. Thromb Res. 2019;173:131–140.

18.

Ferreira

Bota

Bross

Melot

Vincent

. Serial evaluation of the SOFA score to predict outcome in critically ill patients. JAMA. 2001;286(14):1754–1758.

19.

Nolt

Wang

Winter

Williams

. Lactate and immunosuppression in Sepsis. Shock. 2018;49(2):120–125.

20.

Vasileiadis

Politou

Dimopoulos

, et al. Variation of endothelium-related hemostatic factors during sepsis. Microcirculation. 2018;25(8): e12500.

21.

Sieve

Münster-Kühnel

Hilfiker-Kleiner

. Regulation and function of endothelial glycocalyx layer in vascular diseases. Vascul Pharmacol. 2018;100:26–33.

22.

Murphy

Wickersham

McNeil

, et al. Endothelial glycocalyx degradation is more severe in patients with non-pulmonary sepsis compared to pulmonary sepsis and associates with risk of ARDS and other organ dysfunction. Ann Intensive Care. 2017;7(1):102.

23.

Johansen

Johansson

Ostrowski

, et al. Profound endothelial damage predicts impending organ failure and death in sepsis. Semin Thromb Hemost. 2015;41(1):16–25.

24.

Puskarich

Cornelius

Tharp

Nandi

Jones

. Plasma syndecan-1 levels identify a cohort of patients with severe sepsis at high risk for intubation after large-volume intravenous fluid resuscitation. J Crit Care. 2016;36:125–129.

25.

Neves

Meneses

Sousa

NEA

, et al. Syndecan-1 in acute decompensated heart failure–association with renal function and mortality. Circ J. 2015;79(7):1511–1519.

26.

Suetrong

Walley

. Lactic acidosis in sepsis: it’s not all anaerobic: implications for diagnosis and management. Chest. 2016;149(1):252–261.

27.

Alam

Gupta

. Lactate measurements and their association with mortality in pediatric severe sepsis in India: evidence that 6-hour level performs best. J Intensive Care Med. 2020;11:885066620903231.

28.

Semeraro

Ammollo

Semeraro

Colucci

. Coagulopathy of acute sepsis. Semin Thromb Hemost. 2015;41(6):650–658.

29.

Vink

Constantinescu

Spaan

. Oxidized lipoproteins degrade the endothelial surface layer: implications for platelet-endothelial cell adhesion. Circulation. 2000;101(13):1500-1502.

30.

Nieuwdorp

Holleman

de Groot

, et al. Perturbation of hyaluronan metabolism predisposes patients with type 1 diabetes mellitus to atherosclerosis. Diabetologia. 2007;50(6):1288–1293.

31.

Johansson

Stensballe

Rasmussen

Ostrowski

. A high admission syndecan-1 level, a marker of endothelial glycocalyx degradation, is associated with inflammation, protein C depletion, fibrinolysis, and increased mortality in trauma patients. Ann Surg. 2011;254(2):194–200.

32.

Ostrowski

Haase

Müller

. Association between biomarkers of endothelial injury and hypocoagulability in patients with severe sepsis: a prospective study. Crit Care. 2015;24(19):191.

33.

Mochizuki

Vink

Hiramatsu

, et al. Role of hyaluronic acid glycosaminoglycans in shear-induced endothelium-derived nitric oxide release. Am J Physiol Heart Circ Physiol. 2003;285(2):H722–H726.

34.

Nagy

Freudenberger

Melchior-Becker

, et al. Inhibition of hyaluronan synthesis accelerates murine atherosclerosis: novel insights into the role of hyaluronan synthesis. Circulation. 2010;122(22):2313–2322.

35.

Shworak

Kobayashi

de Agostini

Smits

. Anticoagulant heparan sulfate to not clot—or not? Prog Mol Biol Transl Sci. 2010;93:153–178.

36.

Huang

Han

Liu

, et al. Both UFH and NAH alleviate shedding of endothelial glycocalyx and coagulopathy in LPS-induced sepsis. Exp Ther Med. 2020;19(2):913–922.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.10 MB

0.09 MB